Discover Device Therapies for Heart Failure on Webcast

OSUWexnerbloglogo2014 Discover Device Therapies for Heart Failure on Webcast. In the past, we could prescribe medications or do a heart transplant, but that was about it. Now we have new devices that can help our patients with heart failure. On this CME webcast, we’re going to hear about these new devices to show you how these treatments can help them live longer and better lives. Joining our moderator in the studio are cardiologists and heart failure experts from the Ohio State University. Dr. Rami Kahwash is an Associate Professor of Internal Medicine and he is the Director of the Cardiovascular Research Organization at OSU. And Dr. Sitaramesh Emani is an Assistant Professor of Internal Medicine and the Director of Heart Failure Clinical Trials.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DESCRIBE the primary prevention strategies of the prevention of sudden cardiac death in chronic systolic heart failure and the role of Cardiac Resynchronization therapy (CRT); and UNDERSTAND indications of the new defibrillation strategies (wearable ICD and subcutaneous ICD) in the prevention of sudden cardiac death.

You’ll also learn about the following:

  • Medications versus implantable cardiac defibrillators
  • Implantable cardiac monitoring devices
  • Precautions when caring for patients with a ventricular assist device
  • Complications of ventricular assist devices
  • Investigational devices
  • Current role of the intra-aortic balloon pump

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line CME Discussing Multiple Myeloma

OSUWexnerbloglogo2014 On-line CME Discussing Multiple Myeloma. In the past year, there have been 4 new drugs approved to treat multiple myeloma and these are changing the way that we manage patients with this disease. On this CME webcast, we’re going to talk about what multiple myeloma is, how you diagnosis it, and how it is treated. Joining our moderator in the studio is hematologist and Assistant Professor of Internal Medicine from the OSU Wexner Medical Center, Dr. Ashley Rosko. And also from the division of hematology, we have Associate Professor of Internal Medicine, Dr. Yvonne Efebera joining us.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the difference between MGUS, smoldering Myeloma, Symptomatic multiple Myeloma; DESCRIBE the general clinical features of plasma cell myeloma including the diagnosis, and steps required for evaluation; UNDERSTAND Treatment strategy for Newly diagnosed Multiple Myeloma Patients Eligible for Transplant and Newly diagnosed Multiple Myeloma Patients not Eligible for Transplant.

You’ll also learn about the following:

  • Epidemiology of multiple myeloma
  • Prognosis of multiple myeloma
  • When to do a bone marrow biopsy?
  • Screening patients with kidney failure for multiple myeloma
  • Management of hypercalcemia and renal failure in multiple myeloma
  • Autologous versus allogenic stem cell transplant

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches Viewers About Acute Hepatitis

OSUWexnerbloglogo2014 CME Webcast Teaches Viewers About Acute Hepatitis. For his discovery of the virus we now know as hepatitis B and his discovery of a vaccine against it, Dr. Barry Blumberg was awarded the Nobel Prize. At the time of his death, the Scientific Director of the Fox Chase Cancer Center where Blumberg worked said of him: “I think it’s fair to say that Barry prevented more cancer deaths than any person who’s ever lived.” Hepatitis B is only one of a number of viruses as well as drugs and other conditions that can cause acute hepatitis. Here in the studio, with our moderator, to tell us about the different causes of acute hepatitis is hepatologist and Assistant Professor of Internal Medicine, Dr. Sean Kelly. And then to discuss the fundamentals of management of patients with acute liver failure, Associate Professor of Internal Medicine and the Director of the Section of Hepatology at the Ohio State University, Dr. James Hanje.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: IDENTIFY the most common causes of acute hepatitis and characteristics of each type; and IDENTIFY the difference between abnormal liver function tests/acute hepatitis and Acute Liver Failure.

You’ll also learn about the following:

  • Common causes of acute hepatitis
  • New developments in the management of acute liver failure
  • Initial lab testing in patients with acute hepatitis
  • The role of radiographic imaging in evaluation of acute hepatitis
  • Use of the ammonia level in acute liver failure
  • When and how to assess intracranial hypertension

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Get Details about Acute Renal Failure on Webcast

OSUWexnerbloglogo2014 Get Details about Acute Renal Failure on Webcast. On this CME webcast, we’re going to look at acute kidney injury from two unique perspectives. First, to tell us how acute kidney injury is actually a multi-organ system disease, nephrologist and Assistant Professor of Internal Medicine, Dr. Uni Bhatt. And then to tell us about the emerging field of onconephrology, we have Assistant Professor of Internal Medicine also from the Division of Nephrology, Dr. Jason Prosek.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DESCRIBE the changing incidence and mortality of acute kidney injury; DESCRIBE the long term renal and cardiac consequences of acute kidney injury; DISCUSS Treatment algorithm of TKI-induced HTN.

You’ll also learn about the following:

  • Common causes of acute kidney injury
  • Onconephrology
  • The glomerular filtration rate (GFR)
  • Diagnostic approach to the cancer patient with acute kidney injury
  • Cancer-related hypercalcemia
  • Tumor lysis syndrome

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.